Copyright © Queen's Printer,

Victoria, British Columbia, Canada

Licence

Disclaimer

Volume 61, No. 25

261/2018

The British Columbia Gazette,

Part II

December 18, 2018

B.C. Reg. 261/2018 , deposited December 7, 2018, under the PHARMACY OPERATIONS AND DRUG SCHEDULING ACT [section 22 (1)]. Resolution of the Board of the College of Pharmacists of Britis Columbia, dated November 23, 2018.

Resolution of the Board of the College of Pharmacists of British Columbia made the 23rd day of November, 2018, at Vancouver, British Columbia.

RESOLVED THAT, in accordance with the authority established in

section 22 (1) of the Pharmacy Operations and Drug Scheduling Act , and subject to filing with the Minister as required by

section 22 (2) of the Pharmacy Operations and Drug Scheduling Act , the board amend the Drug Schedules Regulation, B.C. Reg. 9/98, as outlined in the

schedule attached to this resolution.

Appendix

1 The Drug Schedules Regulation, B.C. Reg. 9/98, is amended in the Schedules by

adding the following:

1 Phytocannabinoids produced by, or found in, the cannabis plant and substances that are duplicates of such phytocannabinoids, except

(

a) derivatives of cannabis as defined in subsection 2 (1) of the Cannabis Act (Canada) that are exempt from the application of that Act under the Industrial Hemp Regulations (Canada) and that do not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid,

(

b) anything referred to in

Schedule 2 to the Cannabis Act (Canada) that contains no more than 10 µg/g delta-9-tetrahydrocannabinol and that does not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid, or

(

c) anything referred to in the Cannabis Exemption (Food and Drugs Act) Regulations (Canada) that is exempt from the application of the Food and Drugs Act (Canada)

1 Synthetic cannabinoid receptor type-1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomers, as listed in the schedules associated with the Controlled Drugs and Substances Act (Canada) and the Narcotic Control Regulations (Canada) .

— B. NAKAGAWA, Registrar .

Copyright © 2019: Queen's Printer, Victoria, British Columbia, Canada